Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1589.30-20.85 (-1.29 %)
PREV CLOSE () 1610.15
OPEN PRICE () 1612.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 113632
TODAY'S LOW / HIGH ()1583.60 1626.00
52 WK LOW / HIGH ()1547.25 1850.95
NSE1589.30-21.3 (-1.32 %)
PREV CLOSE() 1610.60
OPEN PRICE () 1625.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1589.30 (132)
VOLUME 5796513
TODAY'S LOW / HIGH() 1583.70 1625.00
52 WK LOW / HIGH ()1548 1851.2
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1993

Management Info :

Dilip S Shanghvi - Chairman Kirti Ganorkar - Managing Director

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja, ,
Vadodara,
Gujarat-390012

Phone : 0265- 5515500 / 5515600 / 5515700

Website : www.sunpharma.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
23Jan Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that it enclosed a copy of th..
23Jan Sun Pharma gets DCGI’s nod to manufact
Sun Pharmaceutical Industries has secured approval from the Drugs Contro..
19Jan Clarification sought from Sun Pharmac
The Exchange has sought clarification from Sun Pharmaceutical Industries..
14Jan Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that the Exchange has receive..
26Dec Sun Pharmaceutical’s unit recalls over
Sun Pharmaceutical Industries’ unit -- Taro Pharmaceutical Industries is..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit5642.242826.2
Gross Profit 6717.5 50305.7
Operating Profit 12563.871620.5
Net Sales 45481.1230033.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Gland Pharma (BSE)
 1799.40 (6.56%)
M.Cap ( in Cr)
29646.27
NGL Fine-Chem (BSE)
 1785.00 (4.58%)
M.Cap ( in Cr)
1102.78
Acutaas Chemicals (BSE)
 1936.00 (3.84%)
M.Cap ( in Cr)
15850.25
Windlas Biotech (BSE)
 823.95 (4.76%)
M.Cap ( in Cr)
1736.66
Ipca Laboratories (BSE)
 1482.10 (2.36%)
M.Cap ( in Cr)
37601.50
Shareholding Pattern
PROMOTERS 54.48%
MUTUAL FUNDS/UTI 12.09%
NON-INSTITUTION 8.58%
FI/BANKS/INSURANCE 6.66%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX82566.37221.69 (0.27%)
NIFTY25418.9076.15 (0.30%)
Dow Jones 49015.6012.19 (0.02%)
Nasdaq 23857.4540.35 (0.17%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI